本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tyra Biosciences, Inc.

33.41
+0.73002.23%
盘后33.410.00000.00%17:40 EDT
成交量:107.79万
成交额:3,581.57万
市值:19.87亿
市盈率:-15.34
高:33.91
开:32.68
低:32.20
收:32.68
52周最高:40.65
52周最低:8.88
股本:5,948.52万
流通股本:2,507.09万
量比:2.28
换手率:4.30%
股息:- -
股息率:- -
每股收益(TTM):-2.1777
每股收益(LYR):-2.0125
净资产收益率:-36.87%
总资产收益率:-23.64%
市净率:5.13
市盈率(LYR):-16.60

数据加载中...

2025/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/09

重要事件披露

Form 8-K - Current report
2025/03/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/27

重要事件披露

Form 8-K - Current report
2025/02/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

重要事件披露

Form 8-K - Current report
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/06

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/19

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report